SciELO - Scientific Electronic Library Online

vol.140 número7Marcadores de síndrome metabólico como predictores de elevación de alanino aminotransferasa en niñosLeiomiomatosis intravenosa de origen pelviano con extensión intracardiaca: Reporte de dos casos índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Revista médica de Chile

versión impresa ISSN 0034-9887


ORELLANA, Matías; BUTTINGHAUSEN, Valeria; ASPILLAGA M, Augusto  y  CHANDIA C, Mauricio. Hodgkin lymphoma with hepatic involvement treated with dexametasone, gemcitabine and cisplatin as a bridge to standard therapy: Report of one case. Rev. méd. Chile [online]. 2012, vol.140, n.7, pp. 902-905. ISSN 0034-9887.

Background: The initial presentation of Hodgkin lymphoma with liver involvement is rare. In these patients, the standard first-line therapy with ABVD (Adriamycin, Bleomycine, Vinblastine, Dacarbazine) imply an additional risk for liver toxicity. We report a 64-year-old woman who presented with jaundice, choluria, malaise and weight loss. In the initial evaluation she had jaundice and palpable groin lymph nodes. An obstructive biliary disease was ruled out with magnetic resonance imaging studies. A lymph node biopsy showed a Hodgkins lymphoma, Mixed-cellularity subtype. Considering the liver dysfunction, an alternative scheme of chemotherapy with dexamethasone, gemcitabine and cisplatin (GDP) was administered. After 4 cycles, a significant improvement in liver hepatic function tests was reached and a conventional chemotherapy (ABVD) was begun. While the literature provides some low toxicity protocols for patients with liver involvement, favorable results of our clinical case report allows us to postulate GDP as an alternative for salvage therapy in these patients.

Palabras clave : Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug induced liver injury; Hodgkin disease.

        · texto en Español     · pdf en Español